
Hollis-Eden Pharmaceuticals Inc Profile last edited on: 3/17/2022
Developing a new series of small molecule compounds Year Founded
1994Last Involved Year
2000Key People / Management
Richard Hollis -- CEO
Clarence Ahlem -- Vice President
Clarence Ahlem -- Vice President
Location Information
9191 Towne Centre Drive Suite 409
San Diego, CA 92122
San Diego, CA 92122
(858) 587-9333 |
www.harbortx.com |
Public Profile
Hollis-Eden Pharmaceuticals, Inc., a development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of diseases and disorders in which the body is unable to mount an appropriate immune response. Firm's initial development efforts target radiation and chemotherapy induced immune suppression and immune dysregulation caused by infectious diseases such as HIV, malaria and tuberculosis. Company's initial technology development efforts are primarily focused on a series of potent hormones and hormone analogs that we believe are key components of the bodys natural regulatory system. We believe these immune regulating hormones (IRHs) can be used to reestablish host immunity in situations of dysregulation.
Extent of SBIR involvement
Synopsis: Techseeker Business Condition
Headquartered
USAEmployment
97Revenue
$249.0MPublic/Private
Publicly TradedStock Info
OTC : HRBRReceived SBIR $$
NoTechseeker firm in the news
There are no news available.